<DOC>
	<DOCNO>NCT00709683</DOCNO>
	<brief_summary>This study conduct Africa . The aim observational study evaluate incidence adverse event use NovoMix速 30 FlexPen速 normal clinical practice condition .</brief_summary>
	<brief_title>Observational Study Evaluate Safety NovoMix速 30 FlexPen速</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes fail basal insulin without OAD HbA1c great 7.0 % Subjects unlikely comply protocol requirement Subjects previously enrol study Subjects hypersensitivity biphasic insulin aspart excipients Women pregnant , breast feeding woman child bear capacity use reliable contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>